Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Requirements of a Usable Scoring System for Risk Stratification in Patients With Coronary Artery Disease

  • Sung Soo Kim (Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine) ;
  • Hyun Kuk Kim (Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine)
  • Received : 2024.02.28
  • Accepted : 2024.03.05
  • Published : 2024.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Fuster V. The proliferation of scoring systems: trying to keep our heads out of the clouds. J Am Coll Cardiol 2017;69:1640-1.
  2. Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score). Am J Cardiol 2011;107:965-971.e1.
  3. Lee SH, Kim HK, Jeong MH, et al. Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother 2021;7:112-24.
  4. Song PS, Kim J, An SY, et al. The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention. Korean Circ J 2024;54:189-200.
  5. Steensig K, Olesen KK, Madsen M, et al. A novel model for prediction of thromboembolic and cardiovascular events in patients without atrial fibrillation. Am J Cardiol 2020;131:40-8.
  6. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360:2165-75.
  7. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-826.
  8. Lee YJ, Suh Y, Kim JS, et al. Ticagrelor monotherapy after 3-month dual antiplatelet therapy in acute coronary syndrome by high bleeding risk: the subanalysis from the TICO trial. Korean Circ J 2022;52:324-37.
  9. Park MW. Balancing between ischemic and bleeding risk in PCI patients with 'bi-risk'. Korean Circ J 2022;52:338-40.